{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T08:44:14Z","timestamp":1773737054435,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Minufiya University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The breakthrough infection following COVID-19 vaccination has been a subject of concern recently. Evidence suggests\u00a0that COVID-19 vaccine efficacy diminishes over time due to multiple factors related to the host, and vaccine. Coinfection with other pathogens was claimed earlier as a contributing cause for this phenomenon. Hence, we aimed to stratify the association of post-COVID-19 vaccination breakthrough coinfection with\u00a0<jats:italic>Toxoplasma gondii<\/jats:italic>\u00a0(<jats:italic>T. gondii<\/jats:italic>) and its impact on disease severity. This cross-sectional study included 330 COVID-19-vaccinated patients confirmed by RT-PCR. They were also screened for anti-\u00a0<jats:italic>T. gondii<\/jats:italic>\u00a0antibodies using ELISA. <jats:italic>Toxoplasma<\/jats:italic> seropositive cases\u2019 whole blood was screened for DNA using PCR to correlate results with COVID-19 severity. Out of 330 COVID-19 vaccinated patients with breakthrough infection, 34.5% (114 patients) showed positivity for\u00a0<jats:italic>Toxoplasma<\/jats:italic> IgG by ELISA, and none of the cases was IgM positive. Eleven patients (9.6%) of the IgG-positive cases were positive by PCR. Positive PCR cases correlated positively with the\u00a0<jats:italic>Toxoplasma<\/jats:italic> IgG titer (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), and the Cutoff point was 191.5. Molecular analysis of\u00a0<jats:italic>Toxoplasma<\/jats:italic> and COVID-19 severity showed that 8 (72.7%), 1 (9.1%), and 2 cases (18.2%) had mild, moderate, and severe courses of the disease, respectively, with no significant correlation. Our study reported a heightened prevalence of latent toxoplasmosis among mild cases of COVID-19 breakthrough infection. Nevertheless, a discernible correlation between latent toxoplasmosis and COVID-19 severity is lacking. Hence, implementing studies on a larger scale could provide a more comprehensive comprehension of this association.<\/jats:p>","DOI":"10.1038\/s41598-023-44616-3","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T10:03:19Z","timestamp":1697536999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between breakthrough infection with COVID-19 and Toxoplasma gondii: a cross-sectional\u00a0study"],"prefix":"10.1038","volume":"13","author":[{"given":"Marwa A.","family":"Gouda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hind S.","family":"AboShabaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S.","family":"Abdelgawad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliaa Sabry","family":"Abdel Wahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"A. Abd El-Razik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara","family":"Elsaadawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman. A.","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousry","family":"Hawash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"issue":"15","key":"44616_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fawpar.2019.e00053","volume":"18","author":"EA Innes","year":"2019","unstructured":"Innes, E. A., Hamilton, C., Garcia, J. L., Chryssafidis, A. & Smith, D. A one health approach to vaccines against Toxoplasma gondii. Food Waterborne Parasitol. 18(15), e00053. https:\/\/doi.org\/10.1016\/j.fawpar.2019.e00053 (2019).","journal-title":"Food Waterborne Parasitol."},{"key":"44616_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/Foods11162542","author":"P-J Mar\u00edn-Garc\u00eda","year":"2022","unstructured":"Mar\u00edn-Garc\u00eda, P.-J., Planas, N. & Llobat, L. Toxoplasma gondii in foods: Prevalence, control, and safety. Foods (Basel, Switzerland) https:\/\/doi.org\/10.3390\/Foods11162542 (2022)."},{"issue":"11","key":"44616_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s12275-017-7392-5","volume":"55","author":"P Weeratunga","year":"2017","unstructured":"Weeratunga, P. et al. Dense Granule Protein-7 (GRA-7) of Toxoplasma gondii inhibits viral replication in vitro and in vivo. J. Microbiol. 55(11), 909\u2013917. https:\/\/doi.org\/10.1007\/s12275-017-7392-5 (2017).","journal-title":"J. Microbiol."},{"key":"44616_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fcimb.2019.00103","volume":"9","author":"TS Lima","year":"2019","unstructured":"Lima, T. S. & Lodoen, M. B. Mechanisms of human innate immune evasion by Toxoplasma gondii. Front. Cell. Infect. Microbiol. 9, 103. https:\/\/doi.org\/10.3389\/fcimb.2019.00103 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"44616_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fcimb.2019.00461","volume":"9","author":"F Nakashima","year":"2020","unstructured":"Nakashima, F. et al. Serum IgG anti-Toxoplasma gondii antibody concentrations do not correlate nested PCR results in blood donors. Front. Cell. Infect. Microbiol. 9, 461. https:\/\/doi.org\/10.3389\/fcimb.2019.00461 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"47","key":"44616_CR6","doi-asserted-by":"publisher","first-page":"67886","DOI":"10.1007\/s11356-021-17126-w","volume":"28","author":"S Ghaffari","year":"2021","unstructured":"Ghaffari, S. et al. Is COVID-19 associated with latent toxoplasmosis?. Environ. Sci. Pollut. Res. Int. 28(47), 67886\u201367890. https:\/\/doi.org\/10.1007\/s11356-021-17126-w (2021).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"44616_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijsu.2020.04.018","volume":"78","author":"M Nicola","year":"2020","unstructured":"Nicola, M. et al. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int. J. Surg. (London, England) 78, 185\u2013193. https:\/\/doi.org\/10.1016\/j.ijsu.2020.04.018 (2020).","journal-title":"Int. J. Surg. (London, England)"},{"issue":"9","key":"44616_CR8","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/jamainternmed.2020.3313","volume":"180","author":"P Sinha","year":"2020","unstructured":"Sinha, P., Matthay, M. A. & Calfee, C. S. Is a \u201ccytokine storm\u201d relevant to COVID-19?. JAMA Intern. Med. 180(9), 1152\u20131154. https:\/\/doi.org\/10.1001\/jamainternmed.2020.3313 (2020).","journal-title":"JAMA Intern. Med."},{"issue":"6","key":"44616_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay, M. Z., Poh, C. M., R\u00e9nia, L., MacAry, P. A. & Ng, L. F. P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20(6), 363\u2013374. https:\/\/doi.org\/10.1038\/s41577-020-0311-8 (2020).","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"44616_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/MCP.0000000000000666","volume":"26","author":"FW Arnold","year":"2020","unstructured":"Arnold, F. W. & Fuqua, J. L. Viral respiratory infections: A cause of community-acquired pneumonia or a predisposing factor?. Curr. Opin. Pulm. Med. 26(3), 208\u2013214. https:\/\/doi.org\/10.1097\/MCP.0000000000000666 (2020).","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"23","key":"44616_CR11","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff, J. et al. Safety and efficacy of single-dose Ad2.6COV2.S vaccine against Covid-19. N. Engl. J. Med. 384(23), 2187\u20132201. https:\/\/doi.org\/10.1056\/NEJMoa2101544 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"44616_CR12","doi-asserted-by":"publisher","first-page":"1020029","DOI":"10.3389\/fmicb.2022.1020029","volume":"25","author":"L Akoolo","year":"2022","unstructured":"Akoolo, L., Rocha, S. C. & Parveen, N. Protozoan co-infections and parasite influence on the efficacy of vaccines against bacterial and viral pathogens. Front. Microbiol. 25(13), 1020029. https:\/\/doi.org\/10.3389\/fmicb.2022.1020029 (2022).","journal-title":"Front. Microbiol."},{"key":"44616_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s12639-022-01556-5","author":"A Geraili","year":"2023","unstructured":"Geraili, A. et al. Toxoplasmosis and symptoms severity in patients with COVID-19 in referral centers in Northern Iran. J. Parasit. Dis. https:\/\/doi.org\/10.1007\/s12639-022-01556-5 (2023).","journal-title":"J. Parasit. Dis."},{"issue":"1","key":"44616_CR14","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.21608\/ejhm.2022.227005","volume":"87","author":"AA Abdelmoty","year":"2022","unstructured":"Abdelmoty, A. A., Abdeldayem, W. A., Metwally, R. H. & Elshamy, A. M. Evaluation of laboratory parameters and their correlation with Covid-19 severity. Egypt. J. Hosp. Med. 87(1), 1602\u20131607. https:\/\/doi.org\/10.21608\/ejhm.2022.227005 (2022).","journal-title":"Egypt. J. Hosp. Med."},{"issue":"8","key":"44616_CR15","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1128\/jcm.27.8.1787-1792.1989","volume":"27","author":"JL Burg","year":"1989","unstructured":"Burg, J. L., Grover, C. M., Pouletty, P. & Boothroyd, J. C. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J. Clin. Microbiol. 27(8), 1787\u20131792. https:\/\/doi.org\/10.1128\/jcm.27.8.1787-1792.1989 (1989).","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"44616_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13099-021-00427-3","volume":"13","author":"EF Abdel-Hamed","year":"2021","unstructured":"Abdel-Hamed, E. F. et al. Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections. Gut Pathog. 13(1), 29. https:\/\/doi.org\/10.1186\/s13099-021-00427-3 (2021).","journal-title":"Gut Pathog."},{"issue":"12\u201313","key":"44616_CR17","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/s0020-7519(00)00124-7","volume":"30","author":"MT Astrid","year":"2000","unstructured":"Astrid, M. T., Anja, R. H. & Louis, M. W. Toxoplasma gondii: From animals to humans. Int. J. Parasitol. 30(12\u201313), 1217\u20131258. https:\/\/doi.org\/10.1016\/s0020-7519(00)00124-7 (2000).","journal-title":"Int. J. Parasitol."},{"issue":"1","key":"44616_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.parint.2013.08.005","volume":"63","author":"S Fallahi","year":"2014","unstructured":"Fallahi, S. et al. Comparison of the RE and B1 gene for detection of Toxoplasma gondii infection in children with cancer. Parasitol. Int. 63(1), 37\u201341. https:\/\/doi.org\/10.1016\/j.parint.2013.08.005 (2014).","journal-title":"Parasitol. Int."},{"issue":"10","key":"44616_CR19","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.apjtm.2017.09.012","volume":"10","author":"HM Ibrahim","year":"2017","unstructured":"Ibrahim, H. M., Mohamed, A. H., El-Sharaawy, A. A. & El-Shqanqery, H. E. Molecular and serological prevalence of Toxoplasma gondii in pregnant women and sheep in Egypt. Asian Pac. J. Trop. Med. 10(10), 996\u20131001. https:\/\/doi.org\/10.1016\/j.apjtm.2017.09.012 (2017).","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"2","key":"44616_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.14710\/jbtr.v5i2.4840","volume":"5","author":"R Halleyantoro","year":"2019","unstructured":"Halleyantoro, R., Andriyani, Y., Sari, I. P. & Kurniawan, A. Nested PCR methods for detection of Toxoplasma gondii B1 gene in Cerebrospinal Fluid of HIV patients. J. Biomed. Transl. Res. 5(2), 62\u201366. https:\/\/doi.org\/10.14710\/jbtr.v5i2.4840 (2019).","journal-title":"J. Biomed. Transl. Res."},{"issue":"3","key":"44616_CR21","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4314\/ahs.v17i3.7","volume":"17","author":"H Berredjem","year":"2017","unstructured":"Berredjem, H., Aouras, H., Benlaifa, M., Becheker, I. & Djebar, M. R. Contribution of IgG avidity and PCR for the early diagnosis of toxoplasmosis in pregnant women from the North-Eastern region of Algeria. Afr Health Sci. 17(3), 647\u2013656. https:\/\/doi.org\/10.4314\/ahs.v17i3.7 (2017).","journal-title":"Afr Health Sci."},{"issue":"1000125","key":"44616_CR22","first-page":"2","volume":"5","author":"E Farshi","year":"2020","unstructured":"Farshi, E. Cytokine storm response to COVID-19 vaccinations. J. Cytokine Biol. 5(1000125), 2 (2020).","journal-title":"J. Cytokine Biol."},{"issue":"6","key":"44616_CR23","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","volume":"27","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis, E. J. et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe 27(6), 992\u20131000. https:\/\/doi.org\/10.1016\/j.chom.2020.04.009 (2020).","journal-title":"Cell Host Microbe"},{"key":"44616_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fcimb.2019.00136","volume":"9","author":"IA Khan","year":"2019","unstructured":"Khan, I. A., Hwang, S. & Moretto, M. Toxoplasma gondii: CD8 T cells cry for CD4 help. Front. Cell. Infect. Microbiol. 9, 136. https:\/\/doi.org\/10.3389\/fcimb.2019.00136 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"44616_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-021-05021-9","author":"J Flegr","year":"2021","unstructured":"Flegr, J. Toxoplasmosis: An important risk factor for acquiring SARS-CoV-2 infection and a severe course of Covid-19 disease. Parasit Vectors https:\/\/doi.org\/10.1186\/s13071-021-05021-9 (2021).","journal-title":"Parasit Vectors"},{"issue":"2","key":"44616_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.34172\/ijmpes.2021.10","volume":"2","author":"MNM Hamad","year":"2021","unstructured":"Hamad, M. N. M. & Garedaghi, Y. Metals explain the relationship between Toxoplasma gondii, influenza virus, and COVID-19: A Hypothesis. Int. J. Med. Parasitol. Epidemiol. Sci. 2(2), 33\u201334. https:\/\/doi.org\/10.34172\/ijmpes.2021.10 (2021).","journal-title":"Int. J. Med. Parasitol. Epidemiol. Sci."},{"key":"44616_CR27","doi-asserted-by":"publisher","unstructured":"COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021. (2021). MMWR. Morbidity and Mortality Weekly Report, 70(21), 792\u2013793. Doi: https:\/\/doi.org\/10.15585\/mmwr.mm7021e3.","DOI":"10.15585\/mmwr.mm7021"},{"key":"44616_CR28","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3390\/microorganisms11061441","volume":"11","author":"M Galv\u00e1n-Ram\u00edrez","year":"2023","unstructured":"Galv\u00e1n-Ram\u00edrez, M., Salas-Lais, A. G., Mu\u00f1oz-Medina, J. E., Fernandes-Matano, L. & la P\u00e9rezde, L. L. R. R. Association of toxoplasmosis and COVID-19 in a Mexican population. Microorganisms 11, 1441. https:\/\/doi.org\/10.3390\/microorganisms11061441 (2023).","journal-title":"Microorganisms"},{"key":"44616_CR29","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","volume":"399","author":"C Menni","year":"2022","unstructured":"Menni, C. et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: A prospective observational study from the ZOE COVID Study. Lancet (London, England) 399, 1618\u20131624 (2022).","journal-title":"Lancet (London, England)"},{"key":"44616_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2022.100180","volume":"14","author":"E Amanatidou","year":"2022","unstructured":"Amanatidou, E. et al. Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges. Metab. Open 14, 100180. https:\/\/doi.org\/10.1016\/j.metop.2022.100180 (2022).","journal-title":"Metab. Open"},{"issue":"3","key":"44616_CR31","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1007\/s11686-022-00559-9","volume":"67","author":"M Montazeri","year":"2022","unstructured":"Montazeri, M. et al. Exploring the association between latent Toxoplasma gondii Infection and COVID-19 in hospitalized patients: First registry-based study. Acta Parasitol. 67(3), 1172\u20131179. https:\/\/doi.org\/10.1007\/s11686-022-00559-9 (2022).","journal-title":"Acta Parasitol."},{"issue":"1","key":"44616_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.fawpar.2019.e00053","volume":"5","author":"N Kalantari","year":"2015","unstructured":"Kalantari, N. et al. Preliminary study on association between toxoplasmosis and breast cancer in Iran. Asian Pac. J. Trop. Biomed. 5(1), 44\u201347. https:\/\/doi.org\/10.1016\/j.fawpar.2019.e00053 (2015).","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"44616_CR33","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.3390\/ijerph17134809","volume":"17","author":"M Nasiru Wana","year":"2020","unstructured":"Nasiru Wana, M. et al. A review on the prevalence of Toxoplasma gondii in humans and animals reported in Malaysia from 2008\u20132018. Int. J. Environ. Res. Public Health 17, 4809. https:\/\/doi.org\/10.3390\/ijerph17134809 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"2","key":"44616_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.18502\/ijm.v13i2.5986","volume":"13","author":"A Y\u0131lmaz","year":"2021","unstructured":"Y\u0131lmaz, A., Yaz\u0131c\u0131, E. & Turk, C. Assessment of seroprevalence of Toxoplasma gondii in blood donors applied to the blood center of Gazi University Hospital. Iran. J. Microbiol. 13(2), 243\u2013247. https:\/\/doi.org\/10.18502\/ijm.v13i2.5986 (2021).","journal-title":"Iran. J. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44616-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44616-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44616-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:32:42Z","timestamp":1700526762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44616-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["44616"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-44616-3","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"14 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17636"}}